Exagen (XGN) Revenue (2018 - 2026)

Exagen (XGN) has reported Revenue for 9 consecutive years, with $17.3 million the latest figure, recorded in Q1 2026.

• Revenue for Q1 2026 came in at $17.3 million, up 11.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $68.4 million (up 20.55% YoY), and the FY2025 annual result was $66.6 million, up 19.65% from the prior year.
• Revenue was $17.3 million for Q1 2026 at Exagen, up from $16.6 million in the prior quarter.
• Over five years, Revenue peaked at $17.3 million in Q1 2026 and troughed at $7.6 million in Q2 2022.
• Average Revenue over 5 years is $14.0 million, with a median of $14.1 million recorded in 2023.
• Year-over-year, Revenue sank 40.45% in 2022 and surged 85.87% in 2023.
• Over 5 years, Revenue stood at $12.8 million in 2022, then gained by 7.23% to $13.8 million in 2023, then decreased by 0.8% to $13.7 million in 2024, then grew by 21.79% to $16.6 million in 2025, then climbed by 4.06% to $17.3 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $17.3 million in Q1 2026, $16.6 million in Q4 2025, and $17.2 million in Q3 2025.